5/20
08:03 am
ormp
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Medium
Report
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
5/15
07:49 am
ormp
Compugen names David Silberman as finance chief [Seeking Alpha]
Low
Report
Compugen names David Silberman as finance chief [Seeking Alpha]
5/12
10:00 am
ormp
Oramed Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.038 (vs US$0.085 loss in 1Q 2023) [Yahoo! Finance]
Low
Report
Oramed Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.038 (vs US$0.085 loss in 1Q 2023) [Yahoo! Finance]
4/8
08:37 am
ormp
PhaseV to Present at Upcoming Clinical Trial Events and Scientific Meetings, Highlighting the Value of Machine Learning in Drug Development [Yahoo! Finance]
Medium
Report
PhaseV to Present at Upcoming Clinical Trial Events and Scientific Meetings, Highlighting the Value of Machine Learning in Drug Development [Yahoo! Finance]
3/19
09:17 am
ormp
Scilex Holding repays the remaining balance of convertible debentures [Seeking Alpha]
Low
Report
Scilex Holding repays the remaining balance of convertible debentures [Seeking Alpha]